Phase 2b Trial of a NaV1.8 Inhibitor for Acute Pain. | ClinicLens
Nav1.8, a voltage-gated sodium channel expressed in the peripheral nervous system, has a critical role in pain signaling. Previous trials of NaV1.8 inhibitors have shown effectiveness in reducing postoperative pain. We conducted a phase 2b, double-blind, randomized, placebo-contr
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.